RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
27 hedge funds and large institutions have $12.6M invested in Regulus Therapeutics in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
56% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 16
Holders
27
Holding in Top 10
–
Calls
$1.28M
Puts
–
Top Buyers
| 1 | +$49.6K | |
| 2 | +$49K | |
| 3 | +$43.6K | |
| 4 |
Renaissance Technologies
New York
|
+$30.5K |
| 5 |
VF
Virtu Financial
New York
|
+$21K |
Top Sellers
| 1 | -$55K | |
| 2 | -$51K | |
| 3 | -$48.6K | |
| 4 |
Two Sigma Investments
New York
|
-$34K |
| 5 |
GC
Grimes & Company
Westborough,
Massachusetts
|
-$26K |